VaramirStart free · no cardSign in
LGND as of Nov 1 · 15:52 ET
LGNDNasdaqPharmaceutical Preparations

Ligand Pharmaceuticals Inc · Brief

Next report

116 days

Feb 25 · before openest.Q4 FY26
Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±6.8%
avg realized
±3.6%
Feb 27 '25±8.5%▲+0.57%×0.07
May 8 '25±6.2%▼−2.94%×0.48
Aug 7 '25±5.3%▲+2.75%×0.52
Q3 FY25±5.7%▲+9.37%×1.64
Q1 FY26±7.8%▲+2.50%×0.32
May 7 '26±6.2%▼−9.55%×1.55
Q2 FY26±7.1%▼−0.80%×0.11
Q3 FY26±7.5%▼−0.45%×0.06
quarterimplied−10%0+10%realized×
Q3 FY26±7.5%▼−0.45%×0.06
Q2 FY26±7.1%▼−0.80%×0.11
May '26±6.2%▼−9.55%×1.55
Q1 FY26±7.8%▲+2.50%×0.32
Q3 FY25±5.7%▲+9.37%×1.64
Aug '25±5.3%▲+2.75%×0.52
2 older reports
May '25±6.2%▼−2.94%×0.48
Feb '25±8.5%▲+0.57%×0.07
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Feb 25 report · est.

—

Linked exposure

LGND report session

Customers 2

TVTXTravere×0.58JAZZJazz Pharmaceuticals×0.24
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±7.5% into Oct 29 earnings (Oct 28 close).Source
Oct 22impliedImplied move: ±8.2% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.